Metal Stents for the Management of Massive Hemobilia in Patients with Hilum-Involving Cholangiocarcinoma Receiving Multi-Regimen Chemotherapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recent clinical outcomes of multi-regimen chemotherapy in patients with cholangiocarcinoma (CCC) have shown benefits in terms of overall survival. However, repeated endoscopic biliary drainage (EBD) and serious adverse events negatively affect prolongation of the survival period. The aim of this study was to investigate the prevalence of massive hemobilia and the outcomes of its management with fully covered self-expandable metal stents (FC-SEMSs) in patients with hilum-involving CCC receiving multi-regimen chemotherapy. The methods and effects of FCSEMS placement were retrospectively investigated following the occurrence of massive hemobilia during EBD. A total of 356 patients with CCC received multi-regimen chemotherapy. Among them, 181 patients had hilar invasion, and seven patients (3.9%) developed massive hemobilia during repeated EBD using removable stents. In all cases, the tumor encased the right hepatic artery. In six patients (85.7%), hemostasis was immediately and completely achieved by inserting one or two FC-SEMSs proximal to the hilar invasion area. Therefore, if the tumor encases the right hepatic artery, massive hemobilia is likely to occur during multi-regimen chemotherapy. Thus, prompt placement of a FC-SEMS would be an effective treatment option for massive hemobilia in patients with hilum-involving CCC.
Abstract
Recent clinical outcomes of multi-regimen chemotherapy in patients with cholangiocarcinoma (CCC) have shown benefits in terms of overall survival. However, repeated endoscopic biliary drainage (EBD) and serious adverse events negatively affect prolongation of the survival period. The aim of this study was to investigate the prevalence of massive hemobilia and the outcomes of its management with fully covered self-expandable metal stents (FC-SEMSs) in patients with hilum-involving CCC receiving multi-regimen chemotherapy. The methods and effects of FCSEMS placement were retrospectively investigated following the occurrence of massive hemobilia during EBD. A total of 356 patients with CCC received multi-regimen chemotherapy. Among them, 181 patients had hilar invasion, and seven patients (3.9%) developed massive hemobilia during repeated EBD using removable stents. In all cases, the tumor encased the right hepatic artery. In six patients (85.7%), hemostasis was immediately and completely achieved by inserting one or two FC-SEMSs proximal to the hilar invasion area. Therefore, if the tumor encases the right hepatic artery, massive hemobilia is likely to occur during multi-regimen chemotherapy. Thus, prompt placement of a FC-SEMS would be an effective treatment option for massive hemobilia in patients with hilum-involving CCC.
참고문헌 (13)
- Green MH, "Haemobilia", Br J Surg, 88, pp.773~786 (2001)
- Cathcart S, "Hemobilia : an uncommon but notable cause of upper gastrointestinal bleeding", J Clin Gastroenterol, 51, pp.796~804 (2017)
- Nezu Y, "Pseudoaneurysm caused by a self-expandable metal stent : a report of three cases", Endoscopy, 46, pp.248~251 (2014)
- Rai R, "Potentially fatal haemobilia due to inappropriate use of an expanding biliary stent", World J Gastroenterol, 9, pp.2377~2378 (2003)
- Kim JH, "Pseudoaneurysmal rupture of the hepatic artery caused by a biliary plastic stent", Am J Gastroenterol, 116, pp.1371~ (2021)
- Tien T, "Haemobilia in a previously stented hilar cholangiocarcinoma : successful haemostasis after the insertion of fcSEMS", Oxf Med Case Reports, 2020, pp.omaa010~ (2020)
- Saad WE, "Management of bleeding after percutaneous transhepatic cholangiography or transhepatic biliary drain placement", Tech Vasc Interv Radiol, 11, pp.60~71 (2008)
- Bloechle C, "Hemobilia : presentation, diagnosis, and management", Am J Gastroenterol, 89, pp.1537~1540 (1994)
- Song JY, "Massive hemobilia following transpapillary bile duct biopsy treated by using a covered self-expandable metal stent", Endoscopy, 46(Suppl 1UCTN), pp.E161~E162 (2014)
- Bagla P, "Massive hemobilia during endoscopic retrograde cholangiopancreatography in a patient with cholangiocarcinoma : a case report", Endoscopy, 44(Suppl 2 UCTN), pp.E1~ (2012)
- Rerknimitr R, "Treatment of tumor associated hemobilia with a partially covered metallic stent", Endoscopy, 39(Suppl 1), pp.E225~ (2007)
- Eisenhauer EA, "New response evaluation criteria in solid tumours : revised RECIST guideline(version 1. 1)", Eur J Cancer, 45, pp.228~247 (2009)
- Murugesan SD, "Massive hemobilia : a diagnostic and therapeutic challenge", World J Surg, 38, pp.1755~1762 (2014)